Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-09 Purchase |
2024-08-12 5:23 pm |
Gain Therapeutics Inc. | GANX | Mack Gene CFO and Interim CEO |
14,400 | $1.01 | $14,544 | 14,400 (Direct) |
View |
| 2024-08-09 Purchase |
2024-08-12 5:23 pm |
Gain Therapeutics Inc. | GANX | Islam Khalid Executive Chairman |
50,000 | $0.9988 | $49,940 | 930,784 (Indirect Direct) |
View |
| 2024-07-01 Purchase |
2024-07-01 5:00 pm |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
17,000 | $1.2159 | $20,670 | 304,458 (Indirect Direct) |
View |
| 2024-03-28 Purchase |
2024-04-01 4:01 pm |
Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director |
30,000 | $3.859 | $115,770 | 30,000 (Direct) |
View |
| 2023-12-21 Sale |
2023-12-22 4:17 pm |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
206 | $2.46 | $507 | 12,299 (Direct) |
View |
| 2023-12-07 Sale |
2023-12-14 4:01 pm |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
1,820 | $2.5 | $4,550 | 4,855 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Option Award |
2025-03-21 8:00 pm |
N/A 2035-03-20 |
Gain Therapeutics Inc. | GANX | Fuggetta Gianluca See Remark |
50,000 | $0 | 50,000 (Direct) |
View |
| 2025-03-20 Option Award |
2025-03-21 8:00 pm |
N/A 2035-03-20 |
Gain Therapeutics Inc. | GANX | Mack Gene CEO, President |
200,000 | $0 | 200,000 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 9:00 pm |
N/A 2035-01-06 |
Gain Therapeutics Inc. | GANX | Mack Gene CEO, President |
271,325 | $0 | 271,325 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | Islam Khalid Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | Nicaise Claude Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-08 7:44 pm |
N/A 2034-04-08 |
Gain Therapeutics Inc. | GANX | Mack Gene Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-28 9:00 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
20,212 | $0 | 92,016 (Direct) |
View |
| 2024-03-26 Tax Withholding |
2024-03-28 9:00 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
6,085 | $4.06 | 92,016 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 9:30 pm |
N/A 2034-03-21 |
Gain Therapeutics Inc. | GANX | Fuggetta Gianluca See Remark |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 9:30 pm |
N/A 2034-03-21 |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
370,000 | $0 | 370,000 (Direct) |
View |
| 2023-12-20 Exercise |
2023-12-22 4:17 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
637 | $0 | 12,299 (Direct) |
View |
| 2023-10-01 Exercise |
2023-10-03 4:36 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
825 | $0 | 15,750 (Direct) |
View |
| 2023-09-20 Exercise |
2023-09-22 4:34 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
54,900 | $0 | 287,458 (Direct) |
View |
| 2023-09-20 Exercise |
2023-09-22 4:34 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
2,550 | $0 | 13,500 (Direct) |
View |
| 2023-07-01 Exercise |
2023-07-05 4:18 pm |
N/A N/A |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
3,300 | $0 | 13,200 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:40 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | Islam Khalid Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:39 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:38 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:38 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:37 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | Nicaise Claude Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:36 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-12 5:36 pm |
N/A 2033-04-10 |
Gain Therapeutics Inc. | GANX | Ballantyne Charles Evan Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-03-23 Option Award |
2023-03-27 5:28 pm |
N/A 2033-03-23 |
Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-03-23 Option Award |
2023-03-27 5:27 pm |
N/A 2033-03-23 |
Gain Therapeutics Inc. | GANX | Fuggetta Gianluca Principal Accounting Officer |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-03-23 Option Award |
2023-03-27 5:26 pm |
N/A 2033-03-23 |
Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer |
225,000 | $0 | 225,000 (Direct) |
View |
Ownership |
2022-12-21 4:14 pm |
N/A 2032-06-30 |
Gain Therapeutics Inc. | GANX | Fuggetta Gianluca Principal Accounting Officer |
0 | $0 | 10,000 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:14 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director |
384,300 | $0 | 384,300 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:13 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | Islam Khalid Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:11 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director |
10,500 | $0 | 10,500 (Direct) |
View |